• Login
    Search 
    •   SUNScholar
    • University Centres and Units
    • Search
    •   SUNScholar
    • University Centres and Units
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-4 of 4

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis 

    Schneider, H.; Van Rensburg, C.; Schmidt, S.; Aboo, N.; Makela, H.; Naucler, E.; Hallerback, B.; Svedberg, L-E. (2004)
    Background/Aims: An intravenous formulation of esomeprazole has been developed for use in patients where oral administration is not appropriate. This study evaluated safety after 1 and 4 weeks, and efficacy after 4 weeks' ...
    Thumbnail

    Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease 

    Van Zyl J.; Van Rensburg C.; Vieweg W.; Fischer R. (2004)
    Background/Aim: Gastroesophageal reflux disease (GERD) is a prevalent disease associated with a high symptom burden and a reduced quality of life. This multicenter, randomized, double-blind study compared relief from key ...
    Thumbnail

    A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia 

    Emsley R.; Turner H.J.; Schronen J.; Botha K.; Smit R.; Oosthuizen P.P. (2004)
    Background: While the atypical antipsychotics should ultimately reduce the prevalence of tardive dyskinesia, it is likely to remain a significant clinical problem for a long time to come. No strategy has clearly emerged ...
    Thumbnail

    Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder 

    Seedat S.; Stein M.B. (2004)
    Background: Generalized social anxiety disorder (GSAD) is a pervasive form of social anxiety that affects approximately 5% of persons in the community. Among evidence-based pharmacologic treatments for the disorder, selective ...

    Browse

    All of SUNScholarCommunities & CollectionsBy TitleBy AuthorBy AdvisorBy DateBy SubjectBy TypeThis CommunityBy TitleBy AuthorBy AdvisorBy DateBy SubjectBy Type

    My Account

    LoginRegister

    Discover

    AuthorAboo, N. (1)Botha K. (1)Emsley R. (1)Fischer R. (1)Hallerback, B. (1)Makela, H. (1)Naucler, E. (1)Oosthuizen P.P. (1)Schmidt, S. (1)Schneider, H. (1)... View MoreSubjectAdult (4)
    adult (4)
    article (4)
    clinical trial (4)controlled clinical trial (4)
    controlled study (4)
    Female (4)
    female (4)human (4)Humans (4)... View MoreDate Issued
    2004 (4)
    Has File(s)
    No (4)
    Copyright © Stellenbosch University | ISSN-L 2310-7855
    Contact Us